Skip to content

PC MIROIR : Effects of Mirror Therapy in Children With Hemiplegic Cerebral Palsy

PC MIROIR : Effects of Mirror Therapy in Children With Hemiplegic Cerebral Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02131909
Acronym
PC MIROIR
Enrollment
33
Registered
2014-05-06
Start date
2014-02-28
Completion date
2017-11-30
Last updated
2023-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegic Cerebral Palsy

Keywords

unilateral cerebral palsy, children, upper-limb, mirror therapy, bimanual coordination, kinematics analysis

Brief summary

This is a randomized and comparative prospective test, monocentric and controlled (mirror therapy versus bimanual rehabilitation exercises), in single-blind (investigator and occupational therapist 1 do not know the type of rehabilitation performed).

Interventions

PROCEDUREmirror therapy

During a session, the child performs a series of 10 single, bilateral and synchronous movements while viewing the reflected image

PROCEDUREbimanual rehabilitation exercises

During a session, the child performs a series of 10 single, bilateral and synchronous movements while watching his two hands

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Unilateral spastic cerebral palsy as defined by SCPE (Surveillance of Cerebral Palsy in Europe) * Aged 7 to 17 years * MACS (Manual Ability Classification System) 1 to 3 * Extension of the wrist more than 10° * Free, informed and written consent of the parents * Free, informed and written consent of the child * affiliated, via his/her parents, to the Social Security regime

Exclusion criteria

* Other neuromuscular disorders known * Cognitive impairment hampering the understanding of instructions * Upper-limb pain (EVA score \>3) * Restriction of passive range of motion * Visual impairment not allowing the visualization of the upper limb in the mirror * Upper-limb Botulinum toxin injection in upper limb 6 months prior to inclusion

Design outcomes

Primary

MeasureTime frame
Measurement of the AHA (Assisting Hand Assessment) score5 weeks

Secondary

MeasureTime frameDescription
Measurement of the maximal grasp and pinch strengthbaseline, 5 weeks, 10 weekswith a Baseline dynamometer
Evolution of the AHA scorebaseline, 5 weeks, 10 weeksa variance analysis using 2 factors (time, group) is used (between the onset and 5 weeks later, between the onset and 10 weeks later)
Qualitative and quantitative measurement of movementbaseline, 5 weeks, 10 weeksby a kinematic analysis via an Optitrack system
Measurement of the manual abilitybaseline, 5 weeks, 10 weeksby Abilhand-kids questionnaire

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026